| Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics? S Thota, DA Rodrigues, DC Crans, EJ Barreiro Journal of Medicinal Chemistry 61 (14), 5805-5821, 2018 | 399 | 2018 |
| N-Acylhydrazones as drugs S Thota, DA Rodrigues, PSM Pinheiro, LM Lima, CAM Fraga, EJ Barreiro Bioorganic & Medicinal Chemistry Letters 28 (17), 2797-2806, 2018 | 167 | 2018 |
| Synthesis, anticancer, and cytotoxic activities of some mononuclear Ru(II) compounds SS Karki, S Thota, SY Darj, J Balzarini, E De Clercq Bioorganic & Medicinal Chemistry 15 (21), 6632-6641, 2007 | 90 | 2007 |
| Metal Nanoparticles: Synthesis and Applications in Pharmaceutical Sciences S Thota, DC Crans John Wiley & Sons, 2018 | 78 | 2018 |
| EDITORIAL (thematic issue: treatment and diagnosis of diabetes mellitus and its complication: advanced approaches) S Sen, R Chakraborty Mini reviews in medicinal chemistry 15 (14), 1132-1133, 2015 | 55 | 2015 |
| Synthesis, characterization, DNA binding, DNA cleavage, protein binding and cytotoxic activities of Ru (II) complexes S Thota, S Vallala, R Yerra, DA Rodrigues, NM Raghavendra, EJ Barreiro International Journal of Biological Macromolecules 82, 663-670, 2016 | 42 | 2016 |
| Synthesis of thiocarbohydrazide and carbohydrazide derivatives as possible biologically active agents K Gangarapu, S Manda, A Jallapally, S Thota, SS Karki, J Balzarini, ... Medicinal Chemistry Research 23, 1046-1056, 2014 | 42 | 2014 |
| Design, Synthesis and Pharmacological Evaluation of First‐in‐Class Multitarget N‐Acylhydrazone Derivatives as Selective HDAC6/8 and PI3Kα Inhibitors DARFSGFSSP de Sena M. Pinheiro Marina A. Alves Sreekanth Thota Lorrane S ... ChemMedChem, 2020 | 33 | 2020 |
| The use of conformational restriction in medicinal chemistry P de Sena M Pinheiro, DA Rodrigues, R do Couto Maia, S Thota, ... Current topics in medicinal chemistry 19 (19), 1712-1733, 2019 | 29 | 2019 |
| Design, synthesis, characterization, antioxidant and in vitro cytotoxic activities of novel coumarin thiazole derivatives S Thota, K Nadipelly, A Shenkesi, R Yerra Medicinal Chemistry Research 24, 1162-1169, 2015 | 27 | 2015 |
| Microwave assisted synthesis, characterization of some new isatin and thiophene derivatives as cytotoxic and chemopreventive agents K Gangarapu, S Manda, S Thota, R Yerra, S S Karki, J Balzarini, ... Letters in Drug Design & Discovery 9 (10), 934-941, 2012 | 24 | 2012 |
| Novel mononuclear ruthenium (II) compounds in cancer therapy SS Anchuri, S Thota, R Yerra, KP Devarakonda, S Dhulipala Asian Pacific Journal of Cancer Prevention 13 (7), 3293-3298, 2012 | 24 | 2012 |
| Synthesis, spectroscopic characterization, antineoplastic, in vitro-cytotoxic, and antibacterial activities of mononuclear ruthenium (II) complexes S Thota, M Imran, M Udugula, SS Karki, N Kanjarla, R Yerra, J Balzarini, ... Journal of Coordination Chemistry 65 (5), 823-839, 2012 | 23 | 2012 |
| Synthesis, antineoplastic and cytotoxic activities of some mononuclear Ru(II) complexes S Thota, SS Karki, KN Jayaveera, J Balzarini, ED Clercq Journal of Enzyme Inhibition and Medicinal Chemistry 25 (4), 513-519, 2010 | 23 | 2010 |
| Methods for preparation of metal nanoparticles S Iravani, S Thota, DC Crans Metal nanoparticles: synthesis and applications in pharmaceutical sciences …, 2017 | 20 | 2017 |
| Beyond the selective inhibition of histone deacetylase 6 D A Rodrigues, S Thota, C AM Fraga Mini Reviews in Medicinal Chemistry 16 (14), 1175-1184, 2016 | 18 | 2016 |
| Design, synthesis, characterization, cytotoxic and structure activity relationships of novel Ru (II) complexes S Thota, S Vallala, R Yerra, EJ Barreiro Chinese Chemical Letters 26 (6), 721-726, 2015 | 18 | 2015 |
| Synthesis, spectroscopic characterization, in vitro cytotoxic and structure activity relationships of some mononuclear Ru (II) complexes S Thota, S Vallala, M Imran, S Mekala, SS Anchuri, SS Karki, R Yerra, ... Journal of Coordination Chemistry 66 (6), 1031-1045, 2013 | 17 | 2013 |
| Drug Discovery and Development of Antimalarial Agents: Recent Advances. S Thota, R Yerra Current Protein & Peptide Science 17 (3), 275-279, 2016 | 16 | 2016 |
| Structural basis for the agonist action at free) DA Rodrigues, PSM Pinheiro, TTSC Ferreira, S Thota, CAM Fraga Chemical Biology & Drug Design 91 (3), 668-680, 2018 | 15 | 2018 |
Daniel Alencar RodriguesRoyal College of Surgeons in IrelandVerified email at rcsi.com
